Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Gains from Investment Securities: 2018-2024

Historic Gains from Investment Securities for Evolus (EOLS) over the last 7 years, with Dec 2024 value amounting to $7.2 million.

  • Evolus' Gains from Investment Securities fell 104.41% to -$107,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305,000, marking a year-over-year decrease of 106.06%. This contributed to the annual value of $7.2 million for FY2024, which is 57.71% up from last year.
  • Latest data reveals that Evolus reported Gains from Investment Securities of $7.2 million as of FY2024, which was up 57.71% from $4.5 million recorded in FY2023.
  • In the past 5 years, Evolus' Gains from Investment Securities registered a high of $7.2 million during FY2024, and its lowest value of -$2.0 million during FY2020.
  • Its 3-year average for Gains from Investment Securities is $5.8 million, with a median of $5.8 million in 2022.
  • Per our database at Business Quant, Evolus' Gains from Investment Securities crashed by 136.06% in 2020 and then skyrocketed by 413.40% in 2021.
  • Over the past 5 years, Evolus' Gains from Investment Securities (Yearly) stood at -$2.0 million in 2020, then skyrocketed by 413.40% to $6.3 million in 2021, then dropped by 8.51% to $5.8 million in 2022, then declined by 20.94% to $4.5 million in 2023, then surged by 57.71% to $7.2 million in 2024.